Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07814482
PHASE1

Effect of Sacubitril-Valsartan on Estimated Pulmonary Artery Systolic Pressure in Patients With Heart Failure With Reduced Ejection Fraction Heart Failure

Sponsor: Aswan University

View on ClinicalTrials.gov

Summary

Evaluate effect of Sacubitril-Valsartan on estimated pulmonary artery systolic pressure in patient with reduced ejection fraction heart failure

Official title: Effect of (Sacubitril-Valsartan) Drug on Estimated Pulmonary Artery Systolic Pressure

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

59

Start Date

2025-07-05

Completion Date

2026-07-12

Last Updated

2026-09-11

Healthy Volunteers

No

Conditions

Interventions

DRUG

SACUBITRIL - VALSARTAN (formerly LCZ696, ENTRESTO®)

sacubitril-Valsartan is ARNI that is one of the pillars of heart failure treatment, here we study its effect on estimated pulmonary artery systolic pressure and studying its effect on relieving elevated pulmonary pressure symptoms.

Locations (1)

Faculty of medicine- Aswan university

Aswān, Egypt